Clinical Trial Update: Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1 [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating whether lofexidine can reduce stress-related opiate relapse in people treated with naltrexone; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• LOFEXIDINE (LOFEXIDINE)
• Naltrexone (Naltrexone)

Snippet

Sponsor: Yale University | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED | Results posted: 2013-11-20